SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-125576
Filing Date
2022-12-09
Accepted
2022-12-09 06:02:39
Documents
13
Period of Report
2022-12-06
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2232289d1_8k.htm   iXBRL 8-K 31388
2 EXHIBIT 3.1 tm2232289d1_ex3-1.htm EX-3.1 235344
  Complete submission text file 0001104659-22-125576.txt   492923

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ogn-20221206.xsd EX-101.SCH 3027
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ogn-20221206_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ogn-20221206_pre.xml EX-101.PRE 22592
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2232289d1_8k_htm.xml XML 3707
Mailing Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302
Business Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302 551-430-6000
Organon & Co. (Filer) CIK: 0001821825 (see all company filings)

IRS No.: 464838035 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40235 | Film No.: 221453595
SIC: 2834 Pharmaceutical Preparations